TrimRx's Blog
Wegovy Alcohol Use Disorder — Does It Reduce Drinking?
Wegovy (semaglutide) shows emerging evidence of reducing alcohol intake in some patients through GLP-1 receptor pathways affecting reward signaling.
Wegovy Gambling Addiction — The Compulsive Behavior Link
Wegovy doesn’t cause gambling addiction through direct neurochemical action, but GLP-1 receptor changes can unmask compulsive behaviors in predisposed
Wegovy Smoking Cessation — Does It Help You Quit Smoking?
Wegovy doesn’t treat nicotine dependence — it targets GLP-1 receptors for weight loss, not addiction pathways. Here’s what the research shows.
Wegovy Compulsive Shopping — The Impulse Control Link
Wegovy may trigger compulsive shopping in some patients through dopamine pathway changes. We explain the mechanism, warning signs, and what to do if it
Wegovy Social Anxiety — Does GLP-1 Therapy Help or Hurt?
Wegovy doesn’t directly treat social anxiety, but weight loss can improve confidence. Here’s what clinical evidence shows about GLP-1 medications and
Mounjaro Plateau 3 Months — Why Weight Loss Stalls & How to
Weight loss plateaus after three months on Mounjaro happen when metabolic adaptation outpaces GLP-1 signalling. Here’s what to adjust — and when to
Mounjaro Hair Loss — What Patients Need to Know | TrimRx
Mounjaro hair loss affects 5–8% of patients during rapid weight reduction. Here’s the biological mechanism, timeline, and prevention strategies.
Stopped Losing Weight on Mounjaro? (Here’s What’s Happening)
Hit a plateau on Mounjaro? Weight loss stalls are common after 3–4 months due to metabolic adaptation. We explain why it happens and what works to restart
Build Muscle on Mounjaro — Protein, Timing & Resistance Work
Building muscle on Mounjaro requires higher protein intake, strategic resistance training, and overcoming GLP-1’s appetite suppression. Here’s how to do
